SyntekaBio (XKRX:226330) Total Equity : ₩31,228.3 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Total Equity?

SyntekaBio's total equity for the quarter that ended in Dec. 2023 was ₩31,228.3 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

SyntekaBio Total Equity Historical Data

The historical data trend for SyntekaBio's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Total Equity Chart

SyntekaBio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Equity

Get a 7-Day Free Trial

46,110.65

41,540.09

27,627.18

31,460.78

31,228.29

SyntekaBio Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Equity	Get a 7-Day Free Trial															31,460.78	28,807.67	35,617.56	48,987.57	31,228.29

SyntekaBio Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SyntekaBio's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	52916.638	-	21688.348
	=	31,228.3

SyntekaBio's Total Equity for the quarter that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	52916.638	-	21688.348
	=	31,228.3

SyntekaBio Total Equity Related Terms

Thank you for viewing the detailed overview of SyntekaBio's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SyntekaBio (XKRX:226330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512

Website

http://www.syntekabio.co.kr

SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio (XKRX:226330) Headlines

No Headlines